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The catalytic domains of Cir and Cis, comprising the C-terminal region of the A chain (y), disulphide-linked to the B chain, were obtained by 
limited proteolysis of the native proteases with chymotrypsin and plasmin, respectively, and studied by small angle neutron scattering. For Cfs 
(y-B), a molar mass of 45 000 + 5000 g/mol, and a relatively large radius of gyration (Z&) of 28 f 1 A were determined, excluding a single globular 
domain. The corresponding values for Cir (y-B), (90,000 g/mol, R8 = 34 f 1 A) are consistent with a dimer involving the loose packing of two 
(y-B) subunits. Various models of the dimer are discussed in the light of neutron scattering and other data. 
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1. INTRODUCTION 
The catalytic subunit of human Cl, the first compo- 
nent of the classical pathway of complement, is a 
Ca2+-dependent tetrameric association (Cls-Clr-Clr- 
Cls) of two serine proteases, Clr and Cls, which are 
sequentially activated upon binding of C 1 to activators 
[l-3]. Activation occurs in both cases through cleavage 
of a single Arg-Ile bond [4,5], that converts single chain 
proenzymes into active enzymes (Cir, cis) comprising 
two disulphide-linked chains, A (N-terminal) and B (C- 
terminal). Each monomeric protease is thought to be 
organized in at least two functional domains or regions: 
(i) an interaction region (cr) corresponding to the N- 
terminal half of the A chain, responsible for 
Ca2+-dependent C 1 r-C 1 s interaction; (ii) a catalytic do- 
main, comprising the intact B chain and the C-terminal 
7 region of the A chain, connected to each other 
through a single disulphide bridge (Fig. 1). The B 
chains are homologous to trypsin and chymotrypsin, 
whereas regions y comprise two structural motifs (IV 
and V). The catalytic regions have initially been con- 
sidered as domains on the basis of their resistance to 
proteolysis and their globular appearance in electron 
microscopy. Thus, treatment of Cls with plasmin 
yields a (y-B) fragment that is visualized as a 
monomeric globular structure [6], whereas limited pro- 
teolysis of the native Cir-Cir dimer [6-81 ends in a 
truncated (r-B)2 molecule visualized as twin domains. 
However, recent studies by differential scanning 
calorimetry [9] indicate that the (y-B) fragment of Cls 
comprises three independently folded domains, two in 
the y region (motifs IV and V) and one in the catalytic 
B chain. 
With a view to obtain further information about 
th_eir shape and structural organization, the isolated 
Cl s (y-B) and Clr (y-B)2 fragments were studied by 
small angle neutron scattering. The neutron scattering 
curve at small angles from a protein solution provides 
simultaneous and independent measurements of the 
molar mass of the particle formed by the protein in the 
particular solvent, and of its radius of gyration, and 
therefore an indication of the shape. 
2. MATERIALS AND METHODS 
2.1. Materials 
Human plasmin was obtained from Kabi Vitrum, Stockholm, 
Sweden, a_nd bovine cu-chymotrypsin (type IV) was from Sigma. Ac- 
tivated Clr and Cls were isolated from human plasma as described 
previously [lo]. 
2.2._Isolation of the fragments by limited proteolysis 
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diisopropylphosphorofluoridate 
Clr was first blocked with iPr2-P-F as described in [8], and iPr2-P- 
Cir (0.5 mg/ml) in 145 mM NaCI/SO mM triethanolamine 
hydrochloride (pH 7.4) was submitted to limited proteolysis with 
chymotrypsin (4%, w/w) for one hour at 30°C. The reaction was 
stopped by addition of iPr2-P-F to a final concentration of 1 mM, 
and fragment (y-B)2 was purified by high-pressure gel permeation as 
described [8]. CTs (1.0 mg/ml) in 145 mM NaCl/SO mM 
triethanolamine hydrochloride (pH 7.4) was cleaved with plasmin 
(5%, w/w) for 90 min at 37”C, and the Cis (7-B) fragment was 
purified by high-pressure hydrophobic interaction chromatography 
as described [ll]. Based on identification by N-terminal sequence 
analysis [8,11] of the cleavage sites of chymotrypsin and plasmin 
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Neutron scattering data and chemical parameters of the proteins 
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Fig. 1. Schematic representation of the linear structures of the y-B 
fragments obtained by limited proteolysis with chymotrypsin (Clr) 
and plasmin (Cis). The disulphide bridge patterns, and the positions 
of the N-terminal and C-terminal residues of the B chains and y 
fragments are indicated. (H, D, S), histidine, aspartic acid and serine 
residues of the active site. (e) Asn-linked carbohydrates. 
(Fig. l), the M, of the (y-B) fragments of Clr and Cls were 
calculated from the amino acid sequences [ 12-181, plus 2000 for each 
carbohydrate moiety, and estimated as 50300 and 46600, respective- 
ly. Protein concentrations in the samples were measured using values 
of &80,1% = 14.5 for Clr (y-B)2 and 18.3 for Cls (y-B), which were 
determined experimentally by amino acid analysis of protein solu- 
tions of known absorbance at 280 nm. 
2.3. Neutron scattering 
Experiments were done on the Dll camera at the Institut Laue 
Langevin [19]. The wavelength (A) was set at 10 A with a Ah/A of 8%, 
and the sample detector distance was 2.80 m. This gave an observable 
Q range of 0.013 5 Q I; 0.076 A-‘, where the scattering parameter 
Q = (4n sin 6)/h, and B is one-half the scattering angle. Samples were 
placed in quartz cuvettes of optical pathlength 0.100 cm and the 
temperature was controlled at 6°C. Times of sample exposure to the 
beam varied between 15 min and a few hours depending on the 
signal-to-noise ratio. 
The scattered intensity, I(Q), obtained after subtraction of the 
background due to the solvent alone in a similar cell, and calibration 
by the scattering of 0.100 cm of Hz0 [20], was interpreted in the 
Guinier approximation [21]: 
In 1(Q) = In I(0) - (1/3)Ri Qr (1) 
from which the two independent parameters I(O) and Ri were 
calculated. In the case of a monodisperse solution, in which there is 
no correlation between the positions or the orientations of the par- 
ticles, the two parameters have the following meanings: 
I(O) = (Mzcz/N~)(& - e”;z)2 (2) 
Rg = [Ci(bi - p"Vi]IC(bi - e”k’) 
where M2 is the molar mass of the particle in solution (g/mol); cz is 
the concentration of macromolecule in g/cm3; NA is Avogadro’s 
number (mol-‘); bs (cm/g) is the scattering length per gram of 
macromolecule; G is the partial specific volume of the 
macromolecule (cm3/g); bi (cm), vi (cm’) are the scattering length and 
volume, respectively, of the small volume i in the particle; rt (cm) is 
the distance of this volume to the center of mass of the (bi - p’vi) 
distribution (contrast); Vis the total volume of the particle; e” (cm-‘) 
is the scattering length density of the solvent; the summation should 
be over the entire particle [22]. The values of (bz - e”&) required for 
C& (y-B)2 0.050 * 0.005 34 + 1 17.8 
Cls (7-B) 0.025 t 0.002 28 f 1 18.2 
a Values of 1(0)/c (on an absolute scale) and R, from the 
experimental data in the 0.15 M NaCl buffer 
b (b2 - e”;z) values calculated from the chemical compositions of the 
proteins and solvent (see text). The partial specific volumes & 
estimated from the amino acid and sugar compositions were 0.758 
and 0.748 cm3/g for the protein moieties of Cir (y-B)2 and Cis (y- 
B), respectively, and 0.60 cm3/g for the sugars. The value of e0 = 
5.49 x 10’ cme2 was calculated for the 0.15 M NaCl buffer. 
Estimated uncertainties in 1(0)/c and R, include systematic errors 
in the concentration determination and background subtraction 
the analysis were calculated from the chemical compositions of the 
proteins and of the solvent (Table I). The radius of gyration of excess 
scattering amplitude obeys the same laws as its mechanical counter- 
part. The parallel axes theorem applies. It states that the Ri of a body 
about any axis A is equal to R&f,,, + @, where Rcofm is its radius of 
gyration about an axis parallel to A through its center of mass and 
D is the distance between A and the center of mass. 
2.4. Solvent conditions 
The choice of solvent will affect the value of e” (and therefore of 
the contrast) and the background due to incoherent scattering which 
dominates the solvent contribution to the scattering. Replacing Hz0 
by DsO in the protein solvent increases the contrast enormously and 
also reduces the background. However, DzO may not be a suitable 
solvent because it is known to strengthen hydrophobic effects thus 
favouring protein aggregation [23]. 
3. RESULTS AND DISCUSSION 
3.1. Solvent conditions 
Initial neutron scattering studies of the Clr (y-B)2 
fragment were performed in Hz0 and D20 buffers 
(145 mM NaCl/SO mM triethanolamine hydrochloride, 
pH 7.4). The data collected in both cases were not 
satisfactory due to the low solubility of the protein at 
neutral pH (0.4-0.5 mg/ml) and to its marked tenden- 
cy to form aggregates in D20. Further comparative 
studies on Cir (y-B)2 and Cis (y-B) were conducted in 
Hz0 buffer at alkaline pH (0.15 M NaCl/O. 1 M Tris, 
pH 10.0). Both fragments showed increased solubility 
in this solvent (1.5-4.5 mg/ml) and were expected to 
retain a functional conformation, as judged from the 
fact that the ability of proenzyme Clr (y-B)2 to self- 
activate is not modified at pH 10.0 [24]. 
3.2. Neutron scattering 
The Guinier plots of the proteins are shown in Fig. 2. 
The 1(0)/c values interpreted by using the parameters in 
Table I and Eqn. 2 yielded molar ma_sses of 45 000 2 
5000 and 90000 + 8000 g/mol for Cls (y-B) and Clr 
W3)2r respectively, in good agreement with the 
calculated values of the monomer and dimer, respec- 
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Fig. 2: Neutron scattering data plotted in the Guinier approximation 
for Clr (r-B)2 and Cls (7-B). See text for experimental conditions. 
tively. This confirmed that the solutions were 
monodisperse in these conditions. The radii of gyration 
fo_und were 28 -t 1 A and 34 f 1 A for Cis (y-B) and 
Clr (y-B)z, respectively. These are much larger than the 
values expected for monodomain globular proteins of 
the same mass (Fig. 3). Data collected on Cir (y-B)2 in 
2 M NaCl (same buffer as above, pH 10.0) showed no 
significant difference in either R, or 1(0)/c. Thus, these 
high salt concentration conditions, which inhibit ac- 
tivation of the proenzyme form of Clr (y-B)2 [24], do 
not dissociate the dimer or cause gross conformational 
changes. 
3.3. Models 
The proteins were modelled on the basis of the 
following information: (a) the mass, radius of gyration 
values and the parallel axes theorem; (b) the assump- 
tion that the (y-B) subunits have the same R, in Cir and 
Cis; (c) the B chains have a structure similar to that of 
chymotrypsin (Rg = 17 A, M, = 25000) [25,26]; (d) the 
40- 
cir (I-B), l 
101 I 
10000 20000 30000 4oooo 60000 8oooo1ooooo 
M, 
Fig. 3. Dependence of the radii of gyration of proteins on their 
molecular weights. The line (I?: = constant x M,) in logarithmic 
coordinates is for globular proteins such as lysozyme (I?, = 13 f 
0.5 A), ribonuclease (14 * 0.5 A), papain (16 + 0.5 A), and 
hemoglobin (23.5 f 0.5 A) (neutron data_ collected by_ us and 
reference [27]). Data points are shown for Cls (7-B) and Clr (r-B)z. 
y regions comprise two domains, IV and V, of respec- 
tive M, about 8000 and 11000. 
For a particle made up of two components of mass 
ml, m2 and radius of gyration RI, Rz, the parallel axes 
theorem states that: 
mR: = rn,Rf + rnzR$ + mlm& 
where m is the total mass, R, is the radius of gyration 
of the particle and D12 is the distance between the cen- 
tres of mass of the components. In the case of scatter- 
ing data, the m values are equivalent to_(Zi bi - @‘I’) 
values. The equation was applied to Cls (y-B) using 
values in Table I and with R, = 28 A, RI = 17 A (B), 
and R:! = between 15.5 A and 20 A (7) (this broad 
range was taken to allow for different arrangements of 
the two components of 7). Dr2 was calculated to be 
46 A for R2 = 15.5 A (i.e. an approximately globular 
y component) and 43 A for Rz, = 20 A (a very 
elongated-y component). The equation was then ap- 
plied to Clr (y-B)2 with R, = 34 A, RI = R2 = 28 A and 
ml = m2 = half the mass of (y-B)z, to yield a distance 
of 46 A between (y-B) protomers. 
The models tested are shown in Fig. 4. The measured 
R, (28 A) excludes a monodomain globular shape for 
Cis (y-B) (model A) which would have a radius of gyra- 
tion of approximately 20 A (for M, = 45000; Fig. 3). 
The data are in agreement with models (B) and (C). 
Both these models have a larger R, than the globular 
protein arising from a separation between the centres of 
mass of the y and B domains. A separation of 43-46 A 
yields an R, value in agreement with the measured one. 
Model (C) is consistent with the report [9] indicating 
that y is made up of two independently folded do- 
mains. For Cir (Y-B)z, the neutron data exclude models 
(D) and (E) in which the monomers interact end-to-end, 
which have calculated R, values of 49 A and 57 A, 
respectively. The neutron results are compatible with 
models (F) and (G). Both these models represent a loose 
packing of the (7-B) subunits with 46 A between their 
F 
0 ” IV 
@8 
IV v 6 
G 
B v IV 3 6 v IV 
Fig. 4. Models for Cis (7-B) (A, B, C) and Cir (y-B)2 (D, E, F, G). 
The data are only compatible with (B) and (C) for (y-B), and (F) and 
(G) for (y-B)2. See text for discussion. 
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centres of mass, a value similar to the distance between 
the centres of mass of y and B in the monomer. Model 
(F) is consistent with the ‘head-to-tail’ structure pro- 
posed on the basis of chemical cross-linking [8]. Model 
(G) is consistent with electron micrographs of the pro- 
tein obtained by Weiss et al. [7,28]. Further studies are 
necessary in order to discriminate between the two 
alternative models. 
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